These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17560763)

  • 1. [Hemochromatosis in the age of genetics].
    Buffet C
    Presse Med; 2007 Sep; 36(9 Pt 2):1269-70. PubMed ID: 17560763
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history of hemochromatosis.
    Beutler E
    Mayo Clin Proc; 2004 Mar; 79(3):305-6. PubMed ID: 15008601
    [No Abstract]   [Full Text] [Related]  

  • 3. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramuscular deferoxamine in hereditary hemochromatosis.
    Polo-Romero FJ
    Am J Hematol; 2006 Mar; 81(3):225-6. PubMed ID: 16493613
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of correcting transferrin saturation for body mass index in HFE C282Y homozygotes.
    Waalen J; Beutler E
    J Hepatol; 2006 Feb; 44(2):433-4; author reply 434-5. PubMed ID: 16364490
    [No Abstract]   [Full Text] [Related]  

  • 6. Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis.
    Lawless MW; Mankan AK; Ryan AW; Norris S
    Hepatology; 2008 Jul; 48(1):344-5. PubMed ID: 18203149
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary hemochromatosis.
    Franchini M; Veneri D
    Hematology; 2005 Apr; 10(2):145-9. PubMed ID: 16019461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of hemochromatosis linked to HFE gene].
    Brissot P; De Bels F
    Presse Med; 2007 Sep; 36(9 Pt 2):1295-300. PubMed ID: 17553656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the hemochromatosis gene.
    Tavill AS
    N Engl J Med; 1999 Sep; 341(10):755-7. PubMed ID: 10471465
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.
    Olynyk JK; Hagan SE; Cullen DJ; Beilby J; Whittall DE
    Mayo Clin Proc; 2004 Mar; 79(3):309-13. PubMed ID: 15008603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosis.
    Thorstensen K; Asberg A
    J Hepatol; 2006 May; 44(5):1003-4. PubMed ID: 16551484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to the problem of hemochromatosis].
    Bruns W; Michaelis D; Takác A; Langsch HG
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):363-70. PubMed ID: 5998360
    [No Abstract]   [Full Text] [Related]  

  • 14. Solving hemochromatosis with knock-out mice.
    Pietrangelo A
    J Hepatol; 2003 Jan; 38(1):121-3. PubMed ID: 12480572
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload.
    Steiner M; Leiendecker-Foster C; McLaren GD; Snively BM; McLaren CE; Adams PC; Eckfeldt JH
    Transl Res; 2007 Feb; 149(2):92-5. PubMed ID: 17240320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
    de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
    J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of hereditary hemochromatosis.
    Salgia RJ; Brown K
    Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HFE gene mutations are extremely rare in Western sub-Saharan Africa.
    Martins R; Picanço I; Nunes B; Romão L; Faustino P
    Ann Hematol; 2005 Oct; 84(10):686-8. PubMed ID: 15834568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.